Profile
Raymond W.
Urbanski founded CSA, Inc., where he worked as President.
Dr. Urbanski also currently works at Suntory Pharmaceutical, Inc., as Chief Medical Officer, VP-Research & Development.
Dr. Urbanski also formerly worked at GT Biopharma, Inc., as Chairman, President, CEO & Chief Medical Officer from 2018 to 2019, Aventis SA, as Senior Director-US Medical Affairs, Applied BioSciences Corp., as Director in 2020, Pfizer Inc., as Vice President & Medical Head-Established Products from 2008 to 2012, CymaBay Therapeutics, Inc., as Chief Medical Officer from 2011 to 2012, MannKind Corp., as Chief Medical Officer & Vice President from 2015 to 2017, Mylan, Inc., as Chief Medical Officer from 2012 to 2014, and Suntory Pharmaceutical Research Laboratories LLC, as Chief Marketing Officer.
Dr. Urbanski received his doctorate degree from the University of Medicine & Dentistry of New Jersey and doctorate degree from New Jersey Medical School.
Raymond Urbanski active positions
| Companies | Position | Start |
|---|---|---|
| Suntory Pharmaceutical, Inc. | Chief Tech/Sci/R&D Officer | - |
| CSA, Inc. | Founder | - |
Former positions of Raymond Urbanski
| Companies | Position | End |
|---|---|---|
| APPLIED BIOSCIENCES CORP. | Chief Executive Officer | 2020-03-10 |
| GT BIOPHARMA, INC. | Chief Executive Officer | 2019-03-14 |
| MANNKIND CORPORATION | Chief Tech/Sci/R&D Officer | 2017-09-28 |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Chief Tech/Sci/R&D Officer | 2014-08-31 |
| CYMABAY THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2012-05-31 |
Training of Raymond Urbanski
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| New Jersey Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| GT BIOPHARMA, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| APPLIED BIOSCIENCES CORP. | Health Technology |
| Private companies | 6 |
|---|---|
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Aventis SA develops pharmaceuticals and vaccines for preventative medicine. The company is located in Schiltigheim, France. | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
| CSA, Inc. | |
| Suntory Pharmaceutical Research Laboratories LLC | |
| Suntory Pharmaceutical, Inc. |
- Stock Market
- Insiders
- Raymond Urbanski
